A miRNA-Based Gene Therapy Approach to Target Mutated SOD1 in Key Cell Types in Amyotrophic Lateral Sclerosis {ALS}


Published in:
Molecular Therapy, 26, 5, 263-263
Presented at:
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Chicago, IL, May 16-19, 2018
Year:
May 01 2018
Publisher:
Cambridge, CELL PRESS
ISSN:
1525-0016
1525-0024
Laboratories:




 Record created 2018-12-13, last modified 2019-02-23


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)